ShengYa Bio
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
ShengYa Bio - overview
Established
2018
Location
Xiamen, Fujian, China
Primary Industry
Biotechnology
About
Based in Xiamen, China and founded in 2018, ShengYa Biotechnology (Xiamen) Co. , Ltd. , trading as ShengYa Bio, is a biotechnology promotion and service company specializing in the research, development, and production of in vitro diagnostic reagents and equipment. In March 2026, ShengYa Bio raised a series A+ funding.
The company provides in vitro diagnostic reagents and equipment. The company's revenue is generated by selling in vitro diagnostic reagents and equipment. The series A+ round of financing will be mainly used to advance the clinical registration of the company's core products, expand market channels, and develop new products, thereby accelerating the company's commercialization process in the field of molecular diagnostics for women and children.
Current Investors
CDIB Capital Group, Shanghai Chengpu Investment
Primary Industry
Biotechnology
Sub Industries
Biopharmaceuticals, Molecular Science, Genetics & Gene Therapy, Medical Devices & Equipment, Diagnostic Equipment
Verticals
Manufacturing
Company Stage
Series A
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.